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ABSTRACT
Objectives MicroRNA (miRNA) profiles have been 
evaluated in several biospecimens in relation to common 
diseases for which diet may have a considerable 
impact. We aimed at characterising how specific diets 
are associated with the miRNome in stool of vegans, 
vegetarians and omnivores and how this is reflected 
in the gut microbial composition, as this is still poorly 
explored.
Design We performed small RNA and shotgun 
metagenomic sequencing in faecal samples and 
dietary recording from 120 healthy volunteers, equally 
distributed for the different diets and matched for sex 
and age.
Results We found 49 miRNAs differentially expressed 
among vegans, vegetarians and omnivores (adj. p 
<0.05) and confirmed trends of expression levels of 
such miRNAs in vegans and vegetarians compared with 
an independent cohort of 45 omnivores. Two miRNAs 
related to lipid metabolism, miR-636 and miR-4739, 
were inversely correlated to the non- omnivorous diet 
duration, independently of subject age. Seventeen 
miRNAs correlated (|rho|>0.22, adj. p <0.05) with 
the estimated intake of nutrients, particularly animal 
proteins, phosphorus and, interestingly, lipids. In 
omnivores, higher Prevotella and Roseburia and lower 
Bacteroides abundances than in vegans and vegetarians 
were observed. Lipid metabolism- related miR-425- 3p 
and miR-638 expression levels were associated with 
increased abundances of microbial species, such as 
Roseburia sp. CAG 182 and Akkermansia muciniphila, 
specific of different diets. An integrated analysis 
identified 25 miRNAs, 25 taxa and 7 dietary nutrients 
that clearly discriminated (area under the receiver 
operating characteristic curve=0.89) the three diets.
Conclusion Stool miRNA profiles are associated with 
specific diets and support the role of lipids as a driver 
of epigenetic changes and host- microbial molecular 
interactions in the gut.
INTRODUCTION
Dietary habits are strongly related to lifestyle factors 
as well as social life and culture, and all are strictly 
connected with health. Diet and nutrition represent 
relevant risk factors for different metabolic and 
chronic diseases such as steatosis and non- alcoholic 
fatty liver disease, atherosclerosis and cancer.1 
Significance of this study
What is already known on this subject?
 ► The adoption of a vegetarian or vegan diet 
is associated with a lower intake of relevant 
risk factors for chronic diseases, such as 
cardiovascular diseases or cancer. However, 
it is still controversial whether such diets are 
always healthier and recommended for all.
 ► Dietary components can modulate the 
composition and function of the gut 
microbiome and serve as a substrate for 
bacterial metabolism that could influence 
the host health.
 ► A host- gut interplay may modulate the 
effects of the diet. MicroRNAs (miRNAs) 
found in stool may directly regulate specific 
bacterial gene expression and affect gut 
microbial growth, therefore being essential 
for maintaining normal gut microbiota.
What are the new findings?
 ► Diet is associated with stool miRNome 
profile of omnivores, vegetarians and 
vegans, and several miRNAs characterise 
peculiar signatures of the different dietary 
regimes.
 ► MiR-636 and miR-4739, having a significant 
role in lipid metabolism, show expression 
levels inversely related to the duration 
of the non- omnivorous dietary regime, 
independently of age. Furthermore, targets 
of stool miRNAs upregulated in vegetarian/
vegan subjects are enriched in both lipid and 
folate metabolism.
 ► Vegan and vegetarians are characterised by 
high stool levels of miR-425- 3p, an miRNA 
related to lipid metabolism, whose levels in 
stool correlate with the relative abundance 
of specific microbial taxa, including 
Akkermansia muciniphila.
 ► Stool miRNA profiles and microbiome 
composition, together with dietary nutrients, 
can accurately distinguish different diets 
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High- level consumption of red, processed meat and animal fats 
have been associated with an increase in cancer risk, including 
colorectal cancer (CRC),2 while the high intake of dietary fibres 
is considered a protective factor.3
An increasing number of studies showed that vegetarian (VT) 
and vegan (VN) dietary patterns are associated with signifi-
cantly lower levels of the most relevant risk factors for chronic 
diseases (such as body mass index (BMI) or lipid and glucose 
levels) with a consequent reduced risk of incidence or mortality 
for ischaemic heart disease or cancers.4 However, it is difficult to 
discern whether the health advantages attributed to VNs could 
be generalised to VTs or even to moderate meat eaters following 
a healthy diet. Moreover, there is still the need to elucidate 
the precise molecular mechanisms of these associations. So far, 
only very few studies have performed rigorous experiments 
comparing omnivorous, VT and VN subjects as distinct exper-
imental groups. The few available, investigating the molecular 
mechanisms involved with dietary components absorption, were 
generated from cell cultures and animal models.5
In the past few years, microRNAs (miRNAs), small non- coding 
RNAs that modulate gene expression at the post- transcriptional 
level, have been studied in detail as important regulators altered 
in human diseases, including cancer6 and neurodegenerative 
disorders.7 Nutrients and specific diet components have been 
implicated in the modulation of miRNA expression in in vitro/in 
vivo models and, as a consequence, in all the miRNA- mediated 
molecular mechanisms.8 Based on an miRNA candidate 
approach, we performed a pilot study on stool/plasma samples of 
healthy volunteers with different dietary habits and found differ-
ential miRNA expression levels among them.9 Different studies 
reported a relationship between the expression of faecal miRNAs 
and gastrointestinal disorders,10 including CRC.11 12 Then, stool 
samples can represent a proper non- invasive surrogate tissue 
to evaluate the transcriptional and epigenomic changes occur-
ring on the adherence to a different dietary regimen. However, 
many issues remain unsolved regarding the quality and quantity 
of dietary components needed to regulate miRNA expression in 
humans.13 Recently, we clarified certain relationships between 
specific miRNA expression and the inclusion of specific nutri-
ents in the diets of healthy individuals.14
Dietary components can modulate the composition and func-
tion of the gut microbiome15 16 and diets rich in fibres and poor 
in animal- based products (VN/VT regimes, Mediterranean diet) 
may drive a selection of specific taxa.17–19 In parallel, a growing 
number of studies reported the association of a gut microbiome 
dysbiosis with several gastrointestinal and non- gastrointestinal 
diseases, including diabetes,20 inflammatory bowel disease21 and 
cancer.22
Liu and colleagues23 have demonstrated that faecal miRNAs 
directly regulate specific bacterial gene expression and affect 
gut microbial growth, being therefore essential for the mainte-
nance of normal gut microbiota. Moreover, an integrated anal-
ysis of the gut microbiome and small non- coding RNAs in the 
human stool may provide insights for designing more accurate 
tools for diagnostic purposes in CRC.12 Intestinal microbiota 
and miRNAs may interact to regulate host gene expression.24 
However, the interplay existing between gut microbiome and 
miRNA expression profiles in the presence of a specific dietary 
regime is still unknown.
In the present study, the relationship between miRNA profiles 
and the gut microbiome according to different long- term dietary 
regimes was explored. Small non- coding RNA sequencing was 
performed in faecal and plasma samples from 120 healthy volun-
teers with omnivorous, VT and VN dietary habits. In addition, 
gut microbiome was analysed by shotgun metagenomics. The 
results from sequencing were integrated with detailed informa-
tion on food and specific nutrient intake by validated question-
naires to elucidate the existence of molecular characterisation of 
a specific dietary regime.
By DESeq2 analysis, we found 49 miRNAs differentially 
expressed in stool of VNs and VTs in comparison with omni-
vores (Os) (adj. p<0.05). Interestingly, differentially expressed 
miRNAs among the dietary groups are involved in the regula-
tion of lipid and folate metabolism, adipocyte differentiation 
and connected with obesity and obesity- connected diabetes. 
A combination of these miRNAs, microbial taxa and nutrients 
clearly distinguished subjects according to their diet (area under 
the receiver operating characteristic curve (AUC)=0.89).
METHODS
Detailed methods are provided in the online supplemental mate-
rials of the manuscript.
Study population recruitment and dietary information
A cohort of 120 healthy individuals (72 women and 48 men), 
categorised as VTs, VNs and Os, was recruited on a voluntary 
basis in Turin (Italy) between May 2017 and July 2019. Eligible 
subjects were included in the study according to the following 
selection criteria: the associated dietary regime followed for 
more than 1 year, no consumption of antibiotics in the previous 
3 months before sampling, no use of aspirin or other anti- 
inflammatory drugs in the month prior to the sampling, no 
evidence of intestinal and other pathologies, no pregnancy and 
lactation. Three subjects made use of antihypertensive drugs and 
only one made use of a cholesterol- lowering medication. The 
study cohort included the same proportion of VT, VN and O, 
matched for sex and age (figure 1A). Anthropometric data were 
collected for all subjects at the time of sampling. For an inde-
pendent group of unmatched 45 omnivorous healthy individuals 
(31 women and 14 men), stool small RNA- Seq data (performed 
in the same laboratory and with the same protocol/pipeline of 
analysis) were also available for miRNA profiles validation.
All participants signed informed written consent. The design 
of the study, the informed consent and protocols were approved 
by the local Ethics Committee.
All recruited subjects filled in a validated self- administered 
Food Frequency Questionnaire (FFQ) assessing the usual diet, 
together with lifestyle and personal history data, in accordance 
Significance of this study
How might it impact on clinical practice in the foreseeable 
future?
 ► These findings constitute a significant step forward in the 
elucidation of the molecular mechanisms involving host 
and microbial activities associated with dietary component 
absorption and metabolism.
 ► In monitoring adherence to specific dietary regimes, 
where the intake of nutrients should be carefully checked, 
a translational approach of a non- invasive stool miRNA 
profiling may be easily implemented.
 ► An integrated analysis of gut microbiome and faecal 
miRNAs may provide insights for designing more accurate 
personalised dietary patterns and recommendations aimed at 
prevention/treatment of chronic diseases.
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with the European Prospective Investigation into Cancer and 
Nutrition EPIC study standards.25 The FFQ consisted of 248 
questions concerning 188 different food items and included 
photos with two or three sample dishes of definite sizes or refer-
ences to standard portion sizes. The composition in nutrients of 
individual food items was obtained from Italian food composi-
tion tables26 and the average daily intake of macronutrients and 
micronutrients for each volunteer was estimated.
Collection of biological samples
Naturally evacuated faecal samples were obtained from all 
volunteers previously instructed to self- collect the specimen at 
home. Stool were collected in nucleic acid collection and trans-
port tubes with RNA/DNA stabilising solution (Norgen Biotek 
Corp) and stored at −80°C until RNA and DNA extraction.27
Blood samples were collected into EDTA and serum clot activator 
tubes, according to standard phlebotomy procedures, when volun-
teers brought the stool samples to the laboratory. EDTA tubes were 
centrifuged at ×1000 g for 10 min at room temperature and plasma 
was aliquoted and stored at −80°C. Serum tubes were centrifuged at 
×4000 g for 10 min at room temperature, aliquoted and stored at 
−80°C. One aliquot of serum was used for the analyses of vitamin 
B12 and ferritin. The time between blood sample procurement and 
plasma/serum storage was less than 3 hours.
Extraction of total RNA from stool and plasma
Total RNA from stool was extracted using the Stool Total RNA 
Purification Kit (Norgen Biotek Corp) as described in Tarallo et 
al.12
Total RNA was extracted from 200 µL of plasma with the 
miRNeasy plasma/serum mini kit (Qiagen, Hilden, Germany) 
using the QiaCube extractor (Qiagen) following the manufactur-
er’s instructions and as described in the study by Ferrero et al27 
and Sabo et al.28
RNA concentration was quantified by Qubit microRNA Assay 
Kit (Invitrogen).
Extraction of total DNA from stool
The DNA extraction was performed with the QIAamp DNA 
stool MiniKit (QIAGEN) according to the instructions of the 
manufacturer and as described in the study by Tarallo et al12 and 
Thomas et al.22 The DNA quantification was performed with 
Qubit fluorometer (Qubit DNA HS Assay Kit; Invitrogen).
Small RNA sequencing and bioinformatic analyses
Library preparation for small RNA (sRNA) transcripts was 
performed with the NEBNext Multiplex Small RNA Library 
Prep Set for Illumina (Protocol E7330, New England BioLabs, 
USA) as described in the study by Ferrero et al.27 For each sample, 
250 ng of RNA was used as starting material to prepare libraries.
The obtained sequence libraries were subjected to the Illumina 
sequencing pipeline and 50 cycles sequencing- by- synthesis on 
the HiSeq 2000 (Illumina, USA) (in collaboration with Genecore 
Facility at EMBL, Heidelberg, Germany).
Small RNA sequencing analyses were performed using a previ-
ously described approach.12 The reads passing the quality control 
were trimmed from the adapter sequences using Cutadapt 
V.1.10. Trimmed reads were mapped against human miRNA 
Figure 1 (A) Workflow of the study; (B) Radar plots reporting the relative levels of weekly intake of specific food and drinks according to the dietary 
regimens as self- reported in questionnaires; (C) estimated nutrient intake ratio in vegetarians (VT, left panel) and vegans (VN, right panel) with respect 
to the omnivorous diet (O). MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids.
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sequences from miRBase V.2229 using BWA V.0.7.1230 with 
default settings. Summary statistics of the data and alignment 
are reported in online supplemental table 1A,B. Human miRNAs 
were annotated and quantified using two methods called the 
‘knowledge- based’ and ‘position- based’ methods as described in 
Tarallo et al.12 miRNAs whose assigned arms were derived from 
the ‘position- based’ methodology were indicated in italic.
Differential expression analysis was performed with DESeq2 
R package V.1.22.231 using the likelihood ratio test function 
including age and sex as covariates in the model. An miRNA 
was defined as differentially expressed (DEmiRNA) if associ-
ated with a Benjamini- Hochberg (BH)- adjusted p value<0.05 
and supported by more than 15 reads in at least one of the 
dietary groups. The set of DEmiRNAs was overlapped with 
the annotation from Human microRNA Disease Database 
(HMDD) V.3.2,32 considering the annotations associated with 
each miRNA precursor and the database annotations related to 
gastrointestinal cancers, metabolic disorders, immune- related, 
or cardiovascular diseases.
Shotgun metagenomic and bioinformatic analyses
Libraries were prepared using the Nextera DNA Library Prepa-
ration kit (Illumina) and sequenced on an Illumina HiSeq plat-
form as described in the study by Thomas et al.22
Host contamination was removed using the human sequence 
removal procedure from the Human Microbiome Project.33 Raw 
reads were quality- trimmed (Phred score <25) and reads shorter 
than 60 bp were discarded with the SolexaQA++ software.34 
The number of reads obtained for each sample is reported in 
online supplemental table 1C. Taxonomic profiling was carried 
out by using MetaPhlAn 3.35 Functional profiles were obtained 
by HUMAnN 3.0.36
Integration between miRNA expression, nutrient intake and 
taxa
The R package mixOmics was employed for the integration 
of the three datasets (taxonomic profiles, miRNA expression 
profiles and dietary information), using the Data Integration 
Analysis for Biomarker discovery using Latent cOmponents 
(DIABLO) model.37 Datasets were integrated after normalisation 
(scale R function) and removal of near- zero variables (nearZe-
roVar function of R package caret).
Statistical analyses
All statistical analyses were performed using R software V.4.0.4. 
The analysis of the dietary and lifestyle covariates among subject 
groups was performed using the χ2 test for categorical vari-
ables. For continuous covariates, Kruskal- Wallis and Wilcoxon 
rank- Sum tests were performed.
Correlation analysis between DEmiRNA expression and 
nutrient intake was performed using the Spearman method. 
Multiple testing correction was performed using the BH method 
and correlations associated with an adjusted p value<0.05 were 
considered as statistically significant.
The Generalized Linear Regression Model (GLM) was 
computed using the glm R function to assess the relevance of 
subject covariates in explaining the observed stool DEmiRNA 
levels. DEmiRNA levels were considered as the dependent vari-
able of the model while subjects age, sex, BMI, physical activity, 
waist circumference and season of sample collection were consid-
ered as the independent variables of the model. A covariate was 
considered related to DEmiRNA expression if associated with a 
p value<0.05. The relationship between DEmiRNA expression 
and the estimated intake of nutrients was evaluated computing 
a GLM adjusted for age, sex and BMI. The significance of the 
GLM was computed with respect to a null model using F- test 
implemented in the ANOVA R function. Models associated with 
a p value<0.05 were considered statistically significant. The 
contribution of a nutrient to the model was considered signif-
icant if the associated p value was lower than 0.05 and lower 
than those computed for the contribution of sex, age and BMI 
to the model.
Classification accuracy of the features identified by the 
DIABLO analysis was performed using a 10- fold cross- validation 
approach with the Random Forest classifier implemented in 
Weka V.3.8.5 (https://www. cs. waikato. ac. nz/ ml/ weka/). The clas-
sification efficiency was evaluated in terms of AUC.
MiRNA targets functional enrichment analysis
Functional enrichment analysis was performed using RBiomirGS 
V.0.2.1238 considering validated targets of: (1) DEmiRNAs 
coherently differentially expressed in VT and VN with respect 
to O; (2) miRNAs significantly correlated with cluster of nutri-
ents or (3) taxa; (4) DEmiRNAs from the DIABLO analysis. The 
log2FC and adjusted p value computed between the VN and O 
diets were used as inputs for the tool. The gene sets character-
ised by an adjusted p value lower than 0.05 were considered as 
significantly enriched.
MiRNA expression and epigenetic state analysis in intestinal 
tissues
The analysis of miRNA expression in intestinal tissue samples was 
performed considering the data from the TissueAtlas,39 which 
includes miRNA expression levels measured in two colon and 
three small intestine samples. The epigenetic status of miRNA 
coding genes was evaluated using the chromatin status defined 
by the Roadmap Epigenomics Project.40 Specifically, the anal-
ysis was performed considering the 15 statuses (Core 15- state 
model) defined by integrating epigenetic data of duodenum, 
small intestine, colon, rectum mucosa, or colon smooth muscle 
samples. Only mature miRNAs with an univocal genomic locus 
were considered for the analysis.
RESULTS
Study subjects and dietary characteristics
A total of 120 volunteers, divided into 40 Os, 40 VTs and 40 
VNs, were included in the study. The characteristics of the 
subjects and the design of the study are described in table 1 and 
figure 1A, respectively. Subjects following an omnivorous diet 
displayed a slightly higher BMI (kg/m2) compared with the other 
groups (O: 23.6±3.9, VT: 21.9±2.6, VN: 21.8±2.9 kg/m2, in all 
comparisons p<0.05) and waist circumference (O: 83.8±11.6, 
VT: 78.1±8.6, VN:78.9±8.8 cm, in O vs VT, p<0.05) (table 1). 
Days of sample collection were differently distributed for VT and 
VN with respect to O individuals with respect to the different 
seasons of the year (p<0.05) (data not shown).
All the dietary and lifestyle characteristics are reported in 
detail in online supplemental table 2. In serum, the concen-
tration of ferritin was significantly decreased in VT/VN with 
respect to O (p<0.01 and p<0.05, respectively), while vitamin 
B12 was lower in VT with respect to the other two groups. From 
the list of 188 items included in the EPIC questionnaires, the 
analysis was focused on the most representative nutrients char-
acterising the differences in the dietary regimes (consumption 
of meat, processed meat, fish, cheese and dairy products, bread 
and pasta, total vegetables and fruits). The relative weekly intake 
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of specific food and drinks as reported in the subject question-
naires is summarised in figure 1B and online supplemental figure 
1A. A significantly higher intake of nutrients such as vitamin C, 
β-carotene and fibres was found in VN when compared with 
O. Conversely, in the same comparison, a significant decrease in 
vitamin D, animal proteins, retinol and cholesterol was observed 
in VN (figure 1C). In VT, the discrepancies with O were less 
marked but in line with those observed in VN: the only evident 
difference was in a decreased intake of polyunsaturated fatty 
acids in VT when compared with O (figure 1C). The distribution 
of the macronutrient and micronutrient intake among the three 
dietary groups is represented in online supplemental figure 1B.
Stool miRNA profiles according to different diets
After sequencing of stool RNA samples, an average of 64 681 
reads (0.83%) was aligned to known human miRNA sequences 
and a median number of 253, 321 and 310 stool miRNAs were 
detected in O, VT and VN, respectively (online supplemental 
table 1A). Among these miRNAs, 145 (59.43%) were repre-
sented in all the three dietary groups (online supplemental table 
3A).
Fold changes (expressed as log2FC) of miRNA expres-
sion levels of VT and VN compared with O were significantly 
correlated (rho=0.62, p<0.0001), showing a coherent trend 
(figure 2A, upper panel).
Forty- nine miRNAs were significantly differentially expressed 
among the three dietary groups by sex- adjusted and age- adjusted 
differential expression analysis (online supplemental table 3A). 
For these DEmiRNAs, fold changes from the comparisons of VT 
versus O and VN versus O were strongly correlated (rho=0.84, 
p<0.0001) (figure 2A, lower panel). Fifteen DEmiRNAs were 
differentially expressed in both VT and VN (figure 2B) and 
showed a coherent trend of expression: 11 upregulated and 4 
downregulated in comparison with O. Considering the median 
expression of the 49 DEmiRNAs, a gradual change in the expres-
sion levels was observed from O to VN, with VT showing inter-
mediate expression levels of these molecules in stool (figure 2C). 
A GLM adjusted for dietary group, sex, age, BMI, waist circum-
ference, physical activity and the season of the sample collec-
tion showed that BMI, and age and season of sample collection 
contributed significantly in explaining the stool levels, respec-
tively, of 11 and 8 DEmiRNAs out 49 (online supplemental table 
3B). A limited number of DEmiRNAs was significantly affected 
by sex (one miRNA), physical activity (one miRNA) and waist 
circumference (three miRNAs). Correcting the DESeq2 analysis 
for the season of sample collection or BMI confirmed 38 and 
30 DEmiRNAs out of the 49, respectively (online supplemental 
table 3C).
The expression levels of five DEmiRNAs significantly 
decreased with increasing years of non- omnivorous diet 
(p<0.05) (online supplemental table 3D; figure 2D). Among 
them, miR-636, miR-4488-3p and miR-4739 were also signifi-
cantly downregulated in VT/VN in comparison with O (online 
supplemental figure 2A upper panel). In this respect, only the 
expression levels of miR-4488-3p were concomitantly inversely 
correlated with chronological age (online supplemental figure 
2A, lower panel), strengthening the relationship between both 
miR-636 and miR-4739 down- regulation and the extent of a 
non- omnivorous dietary regime.
Clustering analysis of the correlation coefficients between 
estimated nutrient intake and the levels of all the identified 
stool miRNAs highlighted two main clusters composed of 30 
and 8 miRNAs that were significantly correlated with nutrients 
enriched (eg, dietary fibres, plant lipids and vegetable proteins) 
or depleted (eg, animal lipids, animal proteins and sodium) 
in VT and VN, respectively (online supplemental figure 2B). 
Table 1 Study population characteristics
Characteristics Omnivores Vegetarians P value Vegans P value
Sex Females 24 24 – 24 –
Males 16 16 16
Age (years) Mean±SD 40.5±13.2 40.6±11.7 0.95 39.1±11.6 0.76
Range 20.6–64.1 21.1–67.4 18.5–60.6
Years of vegetarian or vegan diet Mean±SD – 9.7±9.0 – 4.8±2.5 –
Range – 0.7–34.5 0.6–13.0
BMI (kg/m2)   23.6±3.9 21.9±2.6 0.05 21.8±2.9 0.03
BMI classes Underweight (≤18.5) 2 2 5
Normal weight (18.5–24.9) 26 33 0.13 30 0.13
Overweight (25–29.9) 9 4 5
Obese (≥30.0) 3 0 0
Missing – 1 –
Waist circumference (cm)   83.8±11.6 78.1±8.6 0.03 78.9±8.8 0.05
Highest level of education attained
(n (%))
Primary or secondary school 15 (37.5) 14 (35.0) 1.00 22 (55.0) 0.18
University or higher 25 (62.5) 26 (65.0) 18 (45.0)
Physical Activity Total Active 2 4 0
Moderately active 16 6 0.02 18 0.09
Moderately inactive 7 18 14
Inactive 15 12 8
Smoking habit Non- smoker 21 23 26
Former smoker 10 15 0.06 10 0.29
Current smoker 9 2 4
For continuous variables, the p value was computed using the Kruskal- Wallis method while χ2 test was used for analysing categorical variables.
Statistically significant values are in bold.
BMI, body mass index.
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Twenty- two miRNAs were among those identified as differen-
tially expressed in VT/VN compared with O (online supple-
mental table 4A). To further explore the relationship between 
the nutrient estimated intake and the stool DEmiRNA levels, 
a GLM regression analysis adjusted for sex, age and BMI was 
performed revealing 56 miRNA- nutrient associations supported 
by both analyses (figure 2E, online supplemental table 4B). 
The nutrients characterised by the highest number of related 
DEmiRNAs were plant lipids (eight miRNAs), followed by 
animal lipids (seven miRNAs), and total/animal proteins and 
phosphorus (six miRNAs). Conversely, among all DEmiRNAs, 
miR-8053 levels were related to the highest number of nutri-
ents (n=9), followed by miR-4277 and miR- 1260a- 3p (for both 
n=8). Out of 56 miRNA- nutrient associations, 28 associations 
involving nutrients not specific to a dietary regime like animal 
proteins/lipids were coherent also even considering the three 
dietary groups separately.
The analysis of HMDD annotations showed that 12 out of the 
49 stool DEmiRNAs were characterised by precursor sequences 
that were related to a specific disease phenotype in different 
studies (n=191) (online supplemental figure 3A and online 
supplemental table 3E).
Validation in stool samples of an independent group of 
omnivores
The expression profiles of the 49 stool DEmiRNAs were also 
investigated in an independent cohort of 45 O analysed in another 
project (see Methods section). All DEmiRNAs were detected in 
stool of the validation cohort and their levels strongly correlated 
Figure 2 (A) Scatter plot reporting the correlation between miRNA expression log2FC resulting from the comparison between VT and O or VN 
and O. The correlation coefficient was computed using the Spearman method. In the upper panel are reported all miRNAs detected in the two 
comparisons; in the lower panel are reported only the DEmiRNAs. (B) Upset plot reporting the number of stool DEmiRNAs overlapped/specific among 
the three comparisons performed. (C) Line plot reporting the median expression of stool DEmiRNAs as distributed in the three dietary groups. MiRNAs 
were separated into downregulated and upregulated based on log2FC computed between VN and O. (D) Scatter plots reporting the normalised 
expression levels of stool DEmiRNAs whose expression decreased in relation with a non- omnivorous diet regime and its duration in time. (E) Network 
representation of the interactions between stool DEmiRNAs (circles) and nutrients (rhombus). The node size is proportional to the total node degree. 
Each edge represents a significant correlation (adjusted p<0.05) also supported by age- corrected, sex- corrected and BMI- corrected GLM analysis. 
Correlation coefficients are represented by the edge colours and width. O, omnivore; VN, vegan; VT, vegetarian
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with those of the 40 O investigated in this study (rho=0.82, 
p<0.0001) (online supplemental figure 3B and online supple-
mental table 3F). Forty- one out of the 49 DEmiRNAs were vali-
dated as significantly differentially expressed in stool of these O 
subjects in comparison with the VT or VN (online supplemental 
figure 3C and online supplemental table 3F). Furthermore, the 
log2FC for these validated miRNAs were positively correlated 
between the two comparisons (rho=0.80 and 0.79, for VT vs O 
and VN vs O, respectively; p<0.0001). Among the eight non- 
significant miRNAs, seven were characterised by a coherent 
log2FC in at least one of the comparisons in both groups of Os.
Plasma miRNA profiles in relation to the diet
An average of 2 124 450 (30.70%) plasma small RNA sequencing 
reads were aligned to miRNA sequences (online supplemental table 
1B). Plasma samples were characterised by a lower fraction of reads 
unmapped to human annotations (mean 2.36%) compared with 
stool (mean 60.75%). A median number of 382, 384 and 385 
miRNAs were detected in plasma samples from O, VT and VN, 
respectively. Most of the miRNAs detected in plasma (n=252, 89%) 
were commonly detected in all three dietary groups.
Differently from miRNA profiles in stool samples, no DEmiRNAs 
were detected in plasma samples comparing the different dietary 
groups (online supplemental table 5A). Among the 49 DEmiRNAs 
obtained in the analysis of stool data, six (miR- 181c- 3p, miR-425- 3p, 
miR-641- 3p, miR-143- 3p, miR- 1260a- 3p, miR-4508- 3p) were also 
detected in plasma samples (online supplemental table 5B). Among 
them, only miR-143- 3p was characterised by higher but still non- 
significantly different expression levels in VT compared with O and 
VN. None of the stool DEmiRNAs was significantly correlated with 
the expression levels of the same miRNA in plasma samples.
Among the other miRNAs detected in plasma samples, 
miR-362- 3p showed the highest positive correlation comparing 
plasma and stool expression levels (rho=0.31, p<0.0001) while let- 
7a-1-3p was inversely correlated between the different biospecimens 
(rho=−0.34, p<0.0001) (online supplemental table 5C).
XenomiR expression levels in stool and plasma
The presence of food- derived non- human miRNAs (xenomiRs) 
was evaluated by analysing the fraction of human- unmapped 
reads. In stool samples, an average of 186 reads (0.005%) from 
the unmapped reads set was assigned to xenomiRs, while on 
plasma, the mapping rate was slightly higher (1290 reads on 
average, 0.87% of human- unmapped reads) (online supple-
mental table 1). Only two xenomiRs (gga- mir-1692 and gma- 
MIR6300) were detected above the expression threshold used 
in our analysis. Interestingly, the stool levels of gma- MIR6300, 
which is annotated in the soy genome (Glycine max), were 
significantly higher (p<0.05) in VT and VN with respect to O 
(online supplemental table 6). For this xenomiR, no sequence 
similarity was found among human miRNAs, while a homolo-
gous sequence was observed in the genome of other edible vege-
tables and fruits (eg, Solanum lycopersicum, Solanum tuberosum 
and Cucumis melo) (online supplemental table 6). Conversely, in 
plasma samples, 11 xenomiRs were detected, with chi- mir- 30d 
(annotated to Capra hircus genome) characterised by the highest 
number of reads. All the 11 miRNAs were annotated to an 
animal species (C. hircus, Gallus gallus, Sus scrofa, Salmo salar 
or Gadus morhua). However, given the high homology of these 
miRNAs with their homologous sequence in humans, a real 
circulating level of these molecules is less reliable. The observed 
reads could be actually related to the sequencing of portions of 
the corresponding miRNA precursor in humans.
Gut microbiome composition and functions and relation to 
faecal miRNAs
Gut microbiome taxonomic composition varied according to 
the different dietary patterns. Among differently abundant taxa, 
Prevotella copri and Roseburia sp. CAG 182 showed higher 
abundance in VT/VN compared with O, while Bacteroides dorei 
(currently Phocaeicola dorei) prevailed in O (p<0.05; figure 3A).
A functional profiling of the gut metagenomes was performed 
with HUMAnN3. Different gut microbiome composition is 
reflected in differential potential activities. The microbiome of 
O showed increased abundance of several metabolic pathways, 
including pathways related to the biosynthesis of amino acids, 
biogenic amines or their precursors (L- isoleucine biosynthesis 
IV, L- arginine biosynthesis I and II, super- pathway of L- lysine, 
L- threonine and L- methionine biosynthesis II, putrescine biosyn-
thesis IV, chorismate biosynthesis from 3- dehydroquinate), as 
well to the biosynthesis of vitamins (formyl- tetrahydrofolate 
biosynthesis, pantothenate and coenzyme A biosynthesis III) 
(FDR<0.05; figure 3B).
Clustering analysis of the correlation coefficient between 
bacterial abundance and stool miRNA expression levels resulted 
in less homogeneous clusters (online supplemental figure 2C). 
Despite two main clusters of bacterial species and miRNAs 
were identified, correlation coefficients were significant only 
on specific bacteria- miRNA pairs. The bacterial species charac-
terised by the highest number of correlated miRNAs (p<0.05) 
were Ruminococcaceae bacterium D5 (11 correlated miRNAs), 
P. copri (n=8) and Phascolarctobacterium succinatutens (n=7). 
Among the miRNAs correlated with bacterial species, 10 were 
significantly differentially expressed in VT/VN compared with 
O (online supplemental table 4A).
Integration of miRNAs, microbiome and diet
The DIABLO model identified a set of 25 DEmiRNAs, 25 taxa 
and 7 dietary nutrients able, all together, to discriminate the three 
groups (figure 3C). As for stool DEmiRNAs, a GLM adjusted 
for age, sex, BMI, physical activity, waist circumference and 
season of sample collection was applied to evaluate the relation-
ship between taxa and subject covariates. Only five species were 
associated with a significant contribution of at least one of these 
variables (online supplemental table 3B). Partial least squares 
discriminant analysis and the hierarchical clustering showed a 
separation of subjects according to their diet (figure 3D,E). To 
assess the robustness of the data reported in this study in discrim-
inating the different dietary groups, a machine learning analysis 
using the combination of these features was applied. The analysis 
confirmed that the identified features were able to discriminate 
efficiently the different dietary groups (average AUC=0.89). As 
expected, higher accuracy was observed in classifying omniv-
orous (AUC=0.95) and VN (AUC=0.94) individuals than VT 
subjects (AUC=0.79).
Two DEmiRNAs, miR-425- 3p and miR-638, attracted our 
interest since they were associated with a coherent higher 
expression in VT/VN compared with both the analysed O groups 
(among those not affected by BMI), they were also identified 
by DIABLO as discriminant features for the different dietary 
regimes, and they were significantly correlated with nutrients 
(figure 2E). Therefore, these DEmiRNAs were further investi-
gated for their relationship with gut microbiome composition. 
Subjects within the highest quartile of miR-425- 3p expression 
levels (regardless of the type of diet) showed a significantly 
higher abundance of Akkermansia muciniphila, Roseburia 
hominis, Roseburia sp. CAG 182, Oscillibacter sp. 57_20, 
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Oscillibacter sp. CAG 241 and R. bacterium D5 compared with 
those in the lowest quartile (figure 3F and online supplemental 
figure 4), while Anaerotruncus colihominis and Flavonifractor 
plautii were more abundant in subjects with the lowest levels 
of the same miRNA. Consistently, higher levels of Roseburia sp. 
CAG 182 and R. bacterium D5, as well as a lower abundance of 
A. colihominis were found in subjects within the highest expres-
sion levels of miR-638.
Enrichment analysis
The miRNA target enrichment analysis was performed to explore 
whether independent sets of relevant stool miRNAs identified 
in this study (ie, all identified DEmiRNAs either upregulated or 
downregulated, miRNAs identified by DIABLO and miRNAs 
correlated with bacterial species or nutrient intake) were 
predicted to regulate common biological processes. A total of 
927 functional terms were significantly enriched (adj. p<0.05) in 
target genes from each set of miRNAs considered (online supple-
mental table 7), with 68 terms enriched in at least three miRNA 
sets concomitantly (figure 4A). Out of them, 66 were enriched 
in miRNAs upregulated in VN/VT, suggesting an inhibition of 
the related process (negative coefficients in figure 4A). In partic-
ular, the terms that were redundantly enriched in the highest 
number of miRNA sets (five sets) were KEGG_One_carbon_
pool_by_folate and GO_Regulation_of_gluconeogenesis_by_
regulation_of_transcription_from_rna_polymerase_ii_promoter. 
Specifically, for KEGG metabolic- related terms, One_carbon_
pool_by_folate and Glyoxylate_and_dicarboxylate_metabolism 
Figure 3 (A) Box plots showing the relative abundance of three bacterial species differentially prevalent among the dietary groups. *Wilcoxon 
rank- sum p<0.05. (B) Heat map reporting the prevalence of metabolic pathways differentially represented among metagenomic profiles of the 
dietary groups. (C) Bar plot showing the loading weights of each DIABLO- selected variable on each component. The colour indicates the dietary 
group in which the variable has the maximum level. (D) Co- inertia analysis quantifying the co- variability between the three datasets (taxonomic 
composition, miRNA, dietary nutrients). Shapes represent the projected coordinates of each subject. The centroid for a given sample between all 
datasets is indicated by the start of the arrow and the location of the same sample in each dataset by the tips of the arrows. The length of the arrow 
is proportional to the divergence between data from different blocks. (E) Heat map showing the result of the hierarchical clustering analysis of 
the subjects based on discriminant variables identified by DIABLO. (F) Box plots reporting the relative abundances of two bacterial species whose 
levels are significantly different in stool of subjects characterised by higher or lower expression of both miR-425- 3p (top) and miR-638 (bottom). O, 
omnivore; VN, vegan; VT, vegetarian.
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were the most represented in the analysis (figure 4B). These 
terms were enriched in the stool DEmiRNAs upregulated in 
VN/VT but also in miRNAs identified by DIABLO and those 
correlated with higher intake of nutrients observed in VN and 
VT. Finally, Arachidonic_acid_metabolism was the sole KEGG 
metabolic- related term enriched for DEmiRNAs downregulated 
in VN/VT.
Analysis of stool DEmiRNA expression and epigenetic state in 
intestinal tissue samples
Finally, we evaluated the expression levels of stool DEmiRNAs 
in intestinal tissues using the data from the TissueAtlas.39 The 
analysis confirmed that 19 DEmiRNAs out of 22 were detectable 
also in the intestine (online supplemental table 8A). In particular, 
miR-143- 3p was the DEmiRNA characterised by the highest 
expression levels in colon samples (average Z- score=2.40), while 
others like miR-638, miR-425- 3p and miR-636 were detected in 
colon/small intestine as well as in different tissue samples of the 
TissueAtlas repository.
Furthermore, since the epigenetic status of a gene locus can 
represent a reliable proxy of an active/repressive transcrip-
tional state, the epigenetic state of DEmiRNA coding genes was 
evaluated in the Roadmap Epigenomics Project.40 The analysis 
confirmed a transcriptionally active epigenetic state in 41 out of 
the 49 stool DEmiRNAs in at least one of the sample types anal-
ysed (online supplemental table 8B). Specifically, colon mucosa 
was associated with the highest number of epigenetically active 
DEmiRNA loci (n=26), followed by duodenum mucosa (n=23), 
Figure 4 (A) Dot plot showing the statistical significance of the functional terms identified as enriched in the target of different groups of stool 
miRNAs differentially expressed among the dietary groups (DEmiRNAs), identified by DIABLO, correlated with nutrient groups or correlated with 
a group of bacterial species. The size of the dot is proportional to the significance while the colour code refers to the coefficient computed by 
RBiomirGS. Negative coefficients are related to process predicted to be downregulated based on the miRNA expression change. Only terms enriched 
in at least two miRNA groups are reported. (B) Table reporting the KEGG metabolic terms enriched in the target of different miRNA groups. The colour- 
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small intestine and colon smooth muscle tissues (n=18). The 
analysis confirmed, in colon smooth muscle samples, a chro-
matin state related to a strong transcription at miR-143 coding 
locus coherently with previous observations.41
DISCUSSION
In the present study, we explored the faecal miRNome of 120 
healthy subjects adhering to a VN, VT or omnivorous diet, 
reporting that miRNA expression levels are affected by diet, 
with a possible relationship with the gut microbiota composi-
tion and function. Forty- nine miRNAs were significantly differ-
entially expressed among the three dietary groups and 15 of 
them showed a consistent trend of expression of upregulation 
or downregulation in both VT and VN in comparison with two 
independent groups of O. These findings suggest a gradual adap-
tation of the miRNome in response to a specific dietary regimen, 
probably as a consequence of the epigenetic and metagenomic 
changes occurring in the gut, which are reflected in stool. Studies 
on human and mouse models have already demonstrated that 
long- term dietary changes drive stable modifications in the host 
epigenome and gut microbiota.42 43 In this respect, in our study, 
two stool DEmiRNAs (miR-636 and miR-4739) showed a clear 
downregulation with the duration of the non- omnivorous diet, 
independently of VT/VN subject’s age. MiR-636, an intragenic 
miRNA coded from the SRSF2 locus, has been found downregu-
lated in blood/serum and adipose tissue of obese subjects44 and, 
on the contrary, upregulated in young subjects with obesity and 
diabetic nephropathy.45 46 In general, this miRNA seems to be 
implicated in weight loss. Garcia- Lacarte and colleagues,47 for 
example, found miR-636 hypomethylated and overexpressed in 
patients with metabolic syndrome who were highly responsive 
to the weight loss regimen. Presumably, the downregulation of 
this miRNA observed in VT and VN may be associated with a 
low- fat diet, ultimately more protective to the risk of obesity 
and diabetes.
MiR-4739 has been reported as a hub in the regulatory network 
mediated by the long non- coding RNA NEAT1.48 NEAT1 works 
as an miRNA sponge and represses the proliferation and fibrosis 
in diabetic nephropathy.49 Therefore, the action of NEAT1 as a 
natural downregulator of miR-4739 may be imitated by a VT 
or VN diet. Moreover, miR-4739 has been associated with the 
induction of adipogenic differentiation of human bone marrow 
stromal cells by targeting low- density lipoprotein receptor- 
related protein 3 (LRP3).50 Several genes related to metabolism, 
including SHMT1 and MKNK2, have been annotated as having 
the highest number of validated interactions with miR-636 and 
miR-4739. SHMT1 codes for serine hydroxymethyltransferase 1, 
a key protein involved in one- carbon metabolism.51 Conversely, 
MKNK2, encoding for MAPK interacting serine/threonine kinase 
2, was recently associated with the lipid metabolism in adipo-
cytes.52 Despite the fact that more data are needed to support an 
miRNA expression modulation on a long- term plant- based diet, 
our data highlight that in stool it is possible to detect miRNAs 
modulating metabolic processes, such as those of lipids, largely 
affected by different dietary regimes.
Some of the other stool DEmiRNAs found in this study are 
dysregulated in different diseases, as retrieved from HMDD, a 
database of experimentally supported human miRNA disease 
associations. MiR-143 was the DEmiRNA associated with 
the highest number of annotations (101 studies), followed by 
miR-124 (44 studies), miR-425 (11 studies) and miR-638 (10 
studies). Interestingly, in our study, all these miRNAs were 
upregulated in stool of both VT/VN when compared with O. 
MiR-143 is an evolutionarily conserved miRNA transcribed as 
bicistronic RNA in a cluster with miR-145. MiR-143/miR-145 
are well- known tumour suppressor miRNAs dysregulated in 
several cancer types, including CRC.53 Consistently, low levels of 
miR-143- 3p have been observed in stool of patients with CRC11 12 
and their upregulation in stool of VT/VN supports the lower 
cancer risk observed in relation to these dietary habits.54 55 These 
two miRNAs target some fundamental tight junction proteins.56 
Nonetheless, miR-143- 3p is a regulator of adipocyte differen-
tiation57 and decreased levels of this miRNA were observed in 
obese individuals compared with normal weight controls in two 
independent studies.58 59 MiR-143/miR-145 cluster has an essen-
tial role in intestinal epithelium regeneration by modulating 
the insulin growth factor signalling pathway.60 Interestingly, in 
a mouse model of colitis, the administration of two probiotics, 
Lactobacillus fermentum and L. salivarius, ameliorated colonic 
damage and, concomitantly, increased miR-143 expression in 
colonic tissue.61 Conversely, miR-124 is active in colon tissues 
and associated with the modulation of an inflammatory response 
by regulating the signal transducer and activator of transcrip-
tion 3 and acetylcholinesterase.62 63 MiR-124- 5p is frequently 
downregulated in CRC tissues.64 In stool of VT/VN, increased 
expression levels of such miRNAs regulating the inflammatory 
response and the maintenance of gut epithelium are coherent 
with the known anti- inflammatory effects of plant- based diets.65
In the past decade, metagenomics has deeply increased our 
knowledge of the composition and function of the gut micro-
biome and how it is shaped by external factors.66 However, to 
the best of our knowledge, only a few studies in humans have 
explored the role of host miRNAs as mediators or interactors 
of the gut microbiome.24 In 2019, Virtue and colleagues67 have 
shown that miR-181 is overexpressed in white adipocytes of 
obese mice and knockout mice were less susceptible to a high- fat 
diet. In the same study, the authors showed that the expression 
of this miRNA is influenced by variations in the mouse gut 
microbiota. MiR-181 was also observed upregulated in the post-
prandial period of a high- saturated fat meal in peripheral blood 
mononuclear cells of healthy individuals,68 supporting a link of 
this miRNA with lipid metabolism. Interestingly, in our study, 
miR- 181c- 3p stool levels progressively increased going from O 
to VN and were inversely correlated with the estimated animal 
lipid intake (Spearman rho=−0.22). A differential expression 
of various lipid- related miRNAs in stool of VT/VN suggests that 
the change in dietary lipid intake may drive effective epigenetic 
changes in the gut, as previously proposed.69 In low- lipid dietary 
intervention studies, the stool levels of these miRNAs could 
represent a valid non- invasive parameter to assess the patient 
adherence and response to the diet.
In the present study, the gut microbiome taxonomic composition 
varied according to the dietary patterns, with P. copri and Rose-
buria sp. CAG 182, having a higher abundance in VT/VN than O. 
Interestingly, A. muciniphila abundance was linked to both diet and 
miRNAs, in agreement with recent observations.24 A. muciniphila is a 
well- known beneficial microbe involved in mucin metabolism whose 
levels are decreased in several diseases, including ulcerative colitis 
and metabolic disorders.70 Previous evidence reported that human 
miRNAs could directly target genes of these bacteria. Specifically, 
Liu and colleagues71 showed that the oral administration of human 
faecal miR- 30c in a mouse model of multiple sclerosis ameliorated 
the disease symptoms by directly targeting A. muciniphila β-galacto-
sidase coding- gene, which in turn increased the bacterial abundance 
in the gut. Despite miR- 30c- 5p was associated with low stool levels 
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Of note, higher stool levels of miR-425- 3p, an miRNA upreg-
ulated in VT/VN, were significantly related to the abundance 
of A. muciniphila in our study. This miRNA was observed as 
significantly downregulated in serum of hyperlipidemic subjects 
in comparison with healthy controls.72 Furthermore, the other 
mature miRNA derived from miR-425 locus, miR-425- 5p, 
was shown to be able to respond to a lipid challenge in mice 
small intestine and to inhibit 3- hydroxy-3- methylglutaryl- CoA 
synthase coding (HMGCS2), a key enzyme of lipid metab-
olism.73 Finally, miR-425- 5p overexpression in adipocytes 
was previously related to the regulation of lipogenesis and 
lipolysis.74 This data further strengthens our hypothesis on the 
role of the different dietary intake of lipids in VT/VN diets as 
a driver of consistent miRNA modulation in the gut. Higher 
stool levels of miR-425- 3p and miR-638 were also significantly 
correlated with Roseburia and R. bacterium D5, which in our 
cohort were significantly more abundant in VT/VN, coherently 
with previous observation.18 75 This data could be a further 
evidence of the important host- microbial interactions mediated 
by diet and epigenetic factors such as miRNAs. In this sense, 
our results on miRNAs could reflect the gut microbiota shifts 
in response to dietary fat recently reviewed by Chadaideh and 
Carmody.76
In the present study, among the three investigated groups, the 
analysis of the dietary information recorded in the EPIC ques-
tionnaires confirmed the expected differences in weekly food 
consumption and estimated daily nutrient intake. Nutrients and 
specific diet components have been implicated in the modulation 
of miRNA expression in in vitro/in vivo models and, as a conse-
quence, in all miRNA- mediated molecular mechanisms.13 In this 
study, vegetable lipids were the nutrients associated with the 
highest number of stool DEmiRNAs, together with animal lipids 
(namely miR-425- 3p, miR-638, miR-8063 and miR-4277), but 
the latter showed an opposite trend. This result is consistent 
with previous evidence on the activity of lipids in modulating 
miRNA expression in different tissues, including gut,77 adipo-
cytes,78 and plasma.79
A functional enrichment analysis was performed to identify 
the candidate downstream signalling and metabolic pathways 
that may be affected by an intestinal miRNA expression modula-
tion, which is reflected in stool samples. This analysis confirmed 
a relationship between the identified stool DEmiRNAs and 
nutrient metabolism. Terms related to fatty acid metabolism 
(namely, Glyoxilate_and_dicarboxylate_metabolism and Phos-
phatidylglycerol_metabolic_process) and those related to folate 
metabolism (eg, One carbon pool by folate, Metabolism of 
folate and pterines and Tetrahydrofolate metabolic process) were 
frequently observed among the targets of miRNAs upregulated 
in stool of VT/VN. In particular, the gene MTHFD2 coding for 
the mitochondrial bifunctional methylenetetrahydrofolate dehy-
drogenase/cyclohydrolase was predicted as a target of two stool 
miRNAs upregulated in both VT/VN (miR-425- 3p, miR-4277) 
(online supplemental table 7). The estimated dietary intake 
of folic acid was also correlated with the stool levels of these 
miRNAs in our analysis. The activity of miRNAs in regulating 
folate metabolism has been previously observed by others.80 We 
can hypothesise that miR-425- 3p and miR-4277 may form a 
negative feedback loop on the increasing level of this nutrient 
in VT/VN. Interestingly, miR-425- 3p was included in the list 
of miRNAs regulated by the activity of nuclear factor erythroid 
2- related factor 2 (Nrf2),81 a transcription factor involved in 
the regulation of metabolism downstream of nutrient- sensing 
pathways, whose activity is pivotal for the gastrointestinal tract 
development and maintenance.82
MiRNAs are present in all eukaryotes: an intriguing aspect 
is that they could potentially ‘traverse’ from plants to animals 
through food via the gastrointestinal tract and access host cellular 
targets, where they could work as bioactive compounds and 
influence recipients’ physio- pathological conditions. However, 
this cross- kingdom interaction is still a topic of debate in the 
scientific community due to the lack of available data.83 Although 
some xenomiRs were detected in the present study, their low 
abundance in our data suggests a non- functional role of these 
molecules. Taking into consideration that xenomiR sequences 
may often be very similar to those of human miRNAs and the 
absence of evidence on the capacity of xenomiRs to resist food 
processing thus impedes a definitive investigation.
This study is the first to integrate stool miRNAs with gut 
microbiota profiles and estimated daily nutrient intake from 
dietary questionnaires. Despite significant differences in BMI 
in the study population, this covariate only narrowly influenced 
our results. Most of the stool identified DEmiRNAs, including 
miR-425- 3p, miR-638, miR-636, miR-143- 3p, miR- 181c- 3p 
and miR-124- 5p, remained significantly differentially expressed 
after adjustment for this variable. Similarly, although individ-
uals have different dietary habits over the course of the year, 
correcting the analysis by time of sample collection only margin-
ally affected the significances of the identified DEmiRNAs.
We also investigated miRNA profiles in plasma samples from 
the same subjects. However, in this biofluid, no significant 
DEmiRNAs were found according to the different dietary habits. 
It is possible that stool may reflect epigenetic changes occurring 
in the intestinal cells as a consequence of a stable dietary habit, 
while plasma samples could better reflect miRNAs characterising 
transient cellular response to nutrition- related stimuli, including 
circulating nutrients, hormones and microbial metabolites. This 
is consistent with previous observations in all the three dietary 
groups between the estimated intake of particular nutrients and 
a set of plasma miRNAs.14 A rising number of available data 
support the modification of faecal miRNA levels as a proxy 
of alteration and response occurring in the gut epithelium.84 
Indeed, the main source of faecal miRNAs is represented by 
intestinal epithelial cells, as described by Liu et al.23 Although, 
in the present study, we did not assess the cell of origins of the 
detected miRNAs, the analysis of the TissueAtlas and Roadmap 
Epigenomics data confirmed that most of the stool DEmiRNAs 
identified in the present study are expressed and active in the 
gut. Interestingly, the analysis also showed a chromatin state 
related to a strong transcription at miR-143 coding locus coher-
ently with previous observations.41 Then, we cannot exclude the 
contribution of other cellular components of the gastrointestinal 
systems, including those from the stromal and immune compart-
ments. This is particularly relevant when trying to understand 
the host- microbiome crosstalk within the complex intestinal 
microenvironment. However, novel co- culturing systems and in 
vitro models reproducing the gut system could be applied based 
on evidence of miRNA and bacteria dysregulation observed 
in faecal samples to improve our understanding of the molec-
ular characteristics of this miRNA- mediated host- microbial 
interaction.85
In conclusion, we hereby present the first large- scale charac-
terisation of faecal miRNAs in relation to different diets and to 
the gut microbial population with the state of the art of high- 
throughput technologies. We show a gradual modulation of the 
human miRNome as a consequence of different dietary regi-
mens with important modifications in miRNAs involved in lipid 
and folate metabolism. Our data also provides novel evidence 
to improve our understanding of the role of small RNAs in the 
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host- microbial crosstalk in physiological and pathological condi-
tions. An integrated analysis of faecal miRNA and gut micro-
biome signatures might provide insights for designing more 
accurate personalised dietary patterns and recommendations 
aimed at the prevention/treatment of chronic diseases. In partic-
ular, in monitoring the adherence to specific dietary regimes, 
where the intake of nutrients should be carefully checked, a 
translational approach of a non- invasive stool miRNA profiling 
may be foreseen.
Author affiliations
1Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Torino, Italy
2Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy
3Department of Computer Science, University of Torino, Torino, Italy
4Department of Clinical and Biological Sciences, University of Torino, Torino, Italy
5Department Agricultural Sciences, University of Naples Federico II, Portici, Napoli, 
Italy
6Task Force on Microbiome Studies, University of Naples Federico II, Napoli, Italy
7Centre for Integrative Biology, University of Trento, Trento, Italy
8Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 
Milano, Italy
Twitter Nicola Segata @nsegata, Ruggero Gaetano Pensa @rupensa and Barbara 
Pardini @BarbaraPardini1
Acknowledgements The authors are very grateful to all volunteers who 
participated with enthusiasm in the study. The authors are also thankful to Dr 
Vladimir Benes (Genecore Facility at EMBL, Heidelberg, Germany) for his kind 
collaboration and advice and to Mr Elton Jarvis Herman for his precious revision of 
the language of the text. The artwork for this study has been created with  BioRender. 
com.
Contributors BP, ST and AN contributed to concept and design; BP, GF, RGP, SG, ST, 
VP and AN to collection and assembly of the data; BP, GF, ST, AF, FC and AN to small 
RNA- Seq data analyses and interpretation; DE, FDF, EP and NS to metagenomic data 
analyses and interpretation; ST, BP, GF, FC, DE, FDF and AN to manuscript writing; all 
authors gave final approval of the version.
Funding This work was supported by Fondazione Umberto Veronesi postdoctoral 
fellowships 2017 and 2018 (recipients, ST and BP), Compagnia di San Paolo Torino, 
Italy (to BP, AN, ST), Lega Italiana per La Lotta contro i Tumori (to FC, BP and AN), 
Fondazione CRT (grant number 2019-0450 to RGP) the European H2020 research 
project Oncobiome (Grant number 825410), and the COST action TRANSCOLONCAN 
(CA17118). DE laboratory received funding from the JPI HDHL- INTIMIC - Knowledge 
Platform of Food, Diet, Intestinal Microbiomics and Human Health (ID 790) grant and 
the PRIN2017 (20174FHBWR_005) grant by the Italian Ministry of University and 
Research.
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval Azienda Ospedaliera “SS. Antonio e Biagio e C. Arrigo” of 
Alessandria. ID: Colorectal_miRNA CEC2014.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement All data relevant to the study are included in the 
article or uploaded as supplementary information. Raw data are available upon 
request to the corresponding author.
Supplemental material This content has been supplied by the author(s). It 
has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have 
been peer- reviewed. Any opinions or recommendations discussed are solely those 
of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and 
responsibility arising from any reliance placed on the content. Where the content 
includes any translated material, BMJ does not warrant the accuracy and reliability 
of the translations (including but not limited to local regulations, clinical guidelines, 
terminology, drug names and drug dosages), and is not responsible for any error 
and/or omissions arising from translation and adaptation or otherwise.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCID iDs
Sonia Tarallo http:// orcid. org/ 0000- 0003- 0887- 2607
Giulio Ferrero http:// orcid. org/ 0000- 0002- 4580- 0680
Francesca Cordero http:// orcid. org/ 0000- 0002- 3143- 3330
Nicola Segata http:// orcid. org/ 0000- 0002- 1583- 5794
Barbara Pardini http:// orcid. org/ 0000- 0001- 9571- 4257
Danilo Ercolini http:// orcid. org/ 0000- 0003- 3061- 9560
Alessio Naccarati http:// orcid. org/ 0000- 0001- 5774- 0905
REFERENCES
 1 Katz DL, Meller S. Can we say what diet is best for health? Annu Rev Public Health 
2014;35:83–103.
 2 Saliba W, Rennert HS, Gronich N, et al. Red meat and processed meat intake and 
risk of colorectal cancer: a population- based case- control study. Eur J Cancer Prev 
2019;28:287–93.
 3 Hullings AG, Sinha R, Liao LM, et al. Whole grain and dietary fiber intake and risk 
of colorectal cancer in the NIH- AARP diet and health study cohort. Am J Clin Nutr 
2020;112:603–12.
 4 Dinu M, Abbate R, Gensini GF, et al. Vegetarian, vegan diets and multiple health 
outcomes: a systematic review with meta- analysis of observational studies. Crit Rev 
Food Sci Nutr 2017;57:3640–9.
 5 Serrano JCE, Jove M, Gonzalo H, et al. Nutridynamics: mechanism(s) of action of 
bioactive compounds and their effects. Int J Food Sci Nutr 2015;66 Suppl 1:S22–30.
 6 Peng Y, Croce CM. The role of microRNAs in human cancer. Signal Transduct Target 
Ther 2016;1:15004.
 7 Sharma S, Lu H- C. microRNAs in neurodegeneration: current findings and potential 
impacts. J Alzheimers Dis Parkinsonism 2018;8:420.
 8 Gavrilas LI, Ionescu C, Tudoran O, et al. The role of bioactive dietary components in 
modulating miRNA expression in colorectal cancer. Nutrients 2016;8:590.
 9 Tarallo S, Pardini B, Mancuso G, et al. Microrna expression in relation to 
different dietary habits: a comparison in stool and plasma samples. Mutagenesis 
2014;29:385–91.
 10 Rashid H, Hossain B, Siddiqua T, et al. Fecal microRNAs as potential biomarkers for 
screening and diagnosis of intestinal diseases. Front Mol Biosci 2020;7:181.
 11 Francavilla A, Turoczi S, Tarallo S, et al. Exosomal microRNAs and other non- coding 
RNAs as colorectal cancer biomarkers: a review. Mutagenesis 2020;35:243–60.
 12 Tarallo S, Ferrero G, Gallo G, et al. Altered fecal small RNA profiles in colorectal cancer 
reflect gut microbiome composition in stool samples. mSystems 2019;4:e00289–19.
 13 García- Segura L, Pérez- Andrade M, Miranda- Ríos J. The emerging role of microRNAs 
in the regulation of gene expression by nutrients. J Nutrigenet Nutrigenomics 
2013;6:16–31.
 14 Ferrero G, Carpi S, Polini B, et al. Intake of natural compounds and circulating 
microRNA expression levels: their relationship investigated in healthy subjects with 
different dietary habits. Front Pharmacol 2020;11:619200.
 15 De Angelis M, Ferrocino I, Calabrese FM, et al. Diet influences the functions of the 
human intestinal microbiome. Sci Rep 2020;10:4247.
 16 Wu GD, Chen J, Hoffmann C, et al. Linking long- term dietary patterns with gut 
microbial enterotypes. Science 2011;334:105–8.
 17 Wu GD, Compher C, Chen EZ, et al. Comparative metabolomics in vegans and 
omnivores reveal constraints on diet- dependent gut microbiota metabolite 
production. Gut 2016;65:63–72.
 18 De Filippis F, Pellegrini N, Vannini L, et al. High- Level adherence to a Mediterranean 
diet beneficially impacts the gut microbiota and associated metabolome. Gut 
2016;65:1812–21.
 19 Meslier V, Laiola M, Roager HM, et al. Mediterranean diet intervention in overweight 
and obese subjects lowers plasma cholesterol and causes changes in the gut 
microbiome and metabolome independently of energy intake. Gut 2020;69:1258–68.
 20 Gross M. Does the gut microbiome hold clues to obesity and diabetes? Curr Biol 
2013;23:R359–62.
 21 Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis 
microbiota. Inflamm Bowel Dis 2009;15:1183–9.
 22 Thomas AM, Manghi P, Asnicar F, et al. Metagenomic analysis of colorectal cancer 
datasets identifies cross- cohort microbial diagnostic signatures and a link with choline 
degradation. Nat Med 2019;25:667–78.
 23 Liu S, da Cunha AP, Rezende RM, et al. The host shapes the gut microbiota via fecal 
microRNA. Cell Host Microbe 2016;19:32–43.
 24 Malmuthuge N, Guan LL. Noncoding RNAs: regulatory molecules of Host- microbiome 
crosstalk. Trends Microbiol 2021;29:713–24.
 25 Riboli E, Hunt KJ, Slimani N, et al. European prospective investigation into cancer 
and nutrition (EPIC): study populations and data collection. Public Health Nutr 
2002;5:1113–24.
 26 Salvini SPM, Gnagnarella P, Maisonneuve P, et al. Banca Dati di Composizione degli 
Alimenti per Studi Epidemiologici in Italia, 1998.
 27 Ferrero G, Cordero F, Tarallo S, et al. Small non- coding RNA profiling in human 
biofluids and surrogate tissues from healthy individuals: description of the diverse and 
most represented species. Oncotarget 2018;9:3097–111.
 28 Sabo AA, Birolo G, Naccarati A, et al. Small non- coding RNA profiling in plasma 
extracellular vesicles of bladder cancer patients by next- generation sequencing: 
expression levels of miR-126- 3p and piR-5936 increase with higher histologic 
 on S
eptem












13Tarallo S, et al. Gut 2021;0:1–13. doi:10.1136/gutjnl-2021-325168
Nutrition
grades. Cancers 2020;12. doi:10.3390/cancers12061507. [Epub ahead of print: 
09 06 2020].
 29 Kozomara A, Birgaoanu M, Griffiths- Jones S. miRBase: from microRNA sequences to 
function. Nucleic Acids Res 2019;47:D155–62.
 30 Li H, Durbin R. Fast and accurate short read alignment with Burrows- Wheeler 
transform. Bioinformatics 2009;25:1754–60.
 31 Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for 
RNA- Seq data with DESeq2. Genome Biol 2014;15:550.
 32 Huang Z, Liu L, Gao Y, et al. Benchmark of computational methods for predicting 
microRNA- disease associations. Genome Biol 2019;20:202.
 33 Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 
2007;449:804–10.
 34 Cox MP, Peterson DA, Biggs PJ. SolexaQA: At- a- glance quality assessment of illumina 
second- generation sequencing data. BMC Bioinformatics 2010;11:485.
 35 Truong DT, Franzosa EA, Tickle TL, et al. MetaPhlAn2 for enhanced metagenomic 
taxonomic profiling. Nat Methods 2015;12:902–3.
 36 Franzosa EA, McIver LJ, Rahnavard G, et al. Species- Level functional profiling of 
metagenomes and metatranscriptomes. Nat Methods 2018;15:962–8.
 37 Singh A, Shannon CP, Gautier B, et al. DIABLO: an integrative approach for identifying 
key molecular drivers from multi- omics assays. Bioinformatics 2019;35:3055–62.
 38 Zhang J, Storey KB. RBiomirGS: an all- in- one miRNA gene set analysis solution 
featuring target mRNA mapping and expression profile integration. PeerJ 
2018;6:e4262.
 39 Ludwig N, Leidinger P, Becker K, et al. Distribution of miRNA expression across human 
tissues. Nucleic Acids Res 2016;44:3865–77.
 40 Kundaje A, Meuleman W, et al. Integrative analysis of 111 reference human 
epigenomes. Nature 2015;518:317–30.
 41 Kent OA, McCall MN, Cornish TC, et al. Lessons from miR-143/145: the importance of 
cell- type localization of miRNAs. Nucleic Acids Res 2014;42:7528–38.
 42 Krautkramer KA, Kreznar JH, Romano KA, et al. Diet- Microbiota interactions mediate 
global epigenetic programming in multiple host tissues. Mol Cell 2016;64:982–92.
 43 Dai Z, Ramesh V, Locasale JW. The evolving metabolic landscape of chromatin biology 
and epigenetics. Nat Rev Genet 2020;21:737–53.
 44 Kim NH, Ahn J, Choi YM, et al. Differential circulating and visceral fat microRNA 
expression of non- obese and obese subjects. Clin Nutr 2020;39:910–6.
 45 Wang R, Hong J, Cao Y, et al. Elevated circulating microRNA-122 is associated with 
obesity and insulin resistance in young adults. Eur J Endocrinol 2015;172:291–300.
 46 Wang L- P, Gao Y- Z, Song B, et al. Micrornas in the progress of diabetic nephropathy: 
a systematic review and meta- analysis. Evid Based Complement Alternat Med 
2019;2019:3513179.
 47 Garcia- Lacarte M, Martinez JA, Zulet MA, et al. Implication of miR-612 and miR-1976 
in the regulation of TP53 and CD40 and their relationship in the response to specific 
weight- loss diets. PLoS One 2018;13:e0201217.
 48 Huang Z, Winata WA, Zhang K, et al. Reconstruction of a lncRNA- Associated 
ceRNA network in endothelial cells under circumferential stress. Cardiol Res Pract 
2020;2020:1481937.
 49 Huang S, Xu Y, Ge X, et al. Long noncoding RNA NEAT1 accelerates the proliferation 
and fibrosis in diabetic nephropathy through activating Akt/mTOR signaling pathway. 
J Cell Physiol 2019;234:11200–7.
 50 Elsafadi M, Manikandan M, Alajez NM, et al. MicroRNA-4739 regulates osteogenic 
and adipocytic differentiation of immortalized human bone marrow stromal cells via 
targeting LRP3. Stem Cell Res 2017;20:94–104.
 51 Ducker GS, Rabinowitz JD. One- Carbon metabolism in health and disease. Cell Metab 
2017;25:27–42.
 52 Merrett JE, Xie J, Psaltis PJ, et al. Mapk- Interacting kinase 2 (Mnk2) regulates 
adipocyte metabolism independently of its catalytic activity. Biochem J 
2020;477:2735–54.
 53 Poli V, Seclì L, Avalle L. The microRNA-143/145 cluster in tumors: a matter of where 
and when. Cancers 2020;12:708.
 54 Craig WJ. Health effects of vegan diets. Am J Clin Nutr 2009;89:1627S–33.
 55 Appleby PN, Key TJ. The long- term health of vegetarians and vegans. Proc Nutr Soc 
2016;75:287–93.
 56 Bi K, Zhang X, Chen W, et al. Micrornas regulate intestinal immunity and gut 
microbiota for gastrointestinal health: a comprehensive review. Genes 2020;11:1075.
 57 Esau C, Kang X, Peralta E, et al. Microrna-143 regulates adipocyte differentiation. J 
Biol Chem 2004;279:52361–5.
 58 Can U, Buyukinan M, Yerlikaya FH. The investigation of circulating microRNAs 
associated with lipid metabolism in childhood obesity. Pediatr Obes 
2016;11:228–34.
 59 Kilic ID, Dodurga Y, Uludag B, et al. Microrna -143 and -223 in obesity. Gene 
2015;560:140–2.
 60 Chivukula RR, Shi G, Acharya A, et al. An essential mesenchymal function for miR-
143/145 in intestinal epithelial regeneration. Cell 2014;157:1104–16.
 61 Rodríguez- Nogales A, Algieri F, Garrido- Mesa J, et al. Differential intestinal anti- 
inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS 
mouse colitis: impact on microRNAs expression and microbiota composition. Mol Nutr 
Food Res 2017;61:1700144.
 62 Koukos G, Polytarchou C, Kaplan JL, et al. Microrna-124 regulates STAT3 expression 
and is down- regulated in colon tissues of pediatric patients with ulcerative colitis. 
Gastroenterology 2013;145:842–52.
 63 Xiao Y- T, Wang J, Lu W, et al. Downregulated expression of microRNA-124 in pediatric 
intestinal failure patients modulates macrophages activation by inhibiting STAT3 and 
AChE. Cell Death Dis 2016;7:e2521.
 64 Xie X- Q, Wang M- J, Li Y, et al. miR-124 intensified oxaliplatin- based chemotherapy by 
targeting CAPN2 in colorectal cancer. Mol Ther Oncolytics 2020;17:320–31.
 65 Medawar E, Huhn S, Villringer A, et al. The effects of plant- based diets on the body 
and the brain: a systematic review. Transl Psychiatry 2019;9:226.
 66 Scholz M, Ward DV, Pasolli E, et al. Strain- level microbial epidemiology and population 
genomics from shotgun metagenomics. Nat Methods 2016;13:435–8.
 67 Virtue AT, McCright SJ, Wright JM, et al. The gut microbiota regulates white 
adipose tissue inflammation and obesity via a family of microRNAs. Sci Transl Med 
2019;11:eaav1892.
 68 Lopez S, Bermudez B, Montserrat- de la Paz S, et al. A microRNA expression signature 
of the postprandial state in response to a high- saturated- fat challenge. J Nutr 
Biochem 2018;57:45–55.
 69 González- Becerra K, Ramos- Lopez O, Barrón- Cabrera E, et al. Fatty acids, 
epigenetic mechanisms and chronic diseases: a systematic review. Lipids Health Dis 
2019;18:178.
 70 Macchione IG, Lopetuso LR, Ianiro G, et al. Akkermansia muciniphila: key 
player in metabolic and gastrointestinal disorders. Eur Rev Med Pharmacol Sci 
2019;23:8075–83.
 71 Liu S, Rezende RM, Moreira TG, et al. Oral administration of miR- 30d from feces 
of MS patients suppresses MS- like symptoms in mice by expanding Akkermansia 
muciniphila. Cell Host Microbe 2019;26:779–94.
 72 Xu S, Sagiv O, Rubin ML, et al. Validation study of the AJCC cancer staging manual, 
eighth edition, staging system for eyelid and periocular squamous cell carcinoma. 
JAMA Ophthalmol 2019;137:537–42.
 73 Ruiz- Roso MB, Gil- Zamorano J, López de Las Hazas MC, et al. Intestinal lipid 
metabolism genes regulated by miRNAs. Front Genet 2020;11:707.
 74 Qi R, Wang J, Wang Q, et al. MicroRNA-425 controls lipogenesis and lipolysis in 
adipocytes. Biochim Biophys Acta Mol Cell Biol Lipids 2019;1864:744–55.
 75 Tomova A, Bukovsky I, Rembert E, et al. The effects of vegetarian and vegan diets on 
gut microbiota. Front Nutr 2019;6:47.
 76 Chadaideh KS, Carmody RN. Host- Microbial interactions in the metabolism of 
different dietary fats. Cell Metab 2021;33:857–72.
 77 Gil- Zamorano J, Tomé-Carneiro J, Lopez de Las Hazas M- C, et al. Intestinal miRNAs 
regulated in response to dietary lipids. Sci Rep 2020;10:18921.
 78 Carpi S, Scoditti E, Massaro M, et al. The extra- virgin olive oil polyphenols 
Oleocanthal and Oleacein counteract inflammation- related gene and 
miRNA expression in adipocytes by attenuating NF-κB activation. Nutrients 
2019;11:2855.
 79 Mantilla- Escalante DC, López de Las Hazas M- C, Gil- Zamorano J, et al. Postprandial 
circulating miRNAs in response to a dietary fat challenge. Nutrients 2019;11:1326.
 80 Beckett EL, Veysey M, Lucock M. Folate and microRNA: bidirectional interactions. Clin 
Chim Acta 2017;474:60–6.
 81 Linna- Kuosmanen S, Tomas Bosch V, Moreau PR, et al. Nrf2 is a key regulator of 
endothelial microRNA expression under proatherogenic stimuli. Cardiovasc Res 
2021;117:1339–57.
 82 Piotrowska M, Swierczynski M, Fichna J, et al. The Nrf2 in the pathophysiology of the 
intestine: molecular mechanisms and therapeutic implications for inflammatory bowel 
diseases. Pharmacol Res 2021;163:105243.
 83 Li Z, Xu R, Li N. Micrornas from plants to animals, do they define a new messenger for 
communication? Nutr Metab 2018;15:68.
 84 Tili E, Michaille J- J, Piurowski V, et al. Micrornas in intestinal barrier function, 
inflammatory bowel disease and related cancers- their effects and therapeutic 
potentials. Curr Opin Pharmacol 2017;37:142–50.
 85 Udayasuryan B, Nguyen TTD, Slade DJ, et al. Harnessing tissue engineering tools to 
Interrogate Host- Microbiota crosstalk in cancer. iScience 2020;23:101878.
 on S
eptem








ut: first published as 10.1136/gutjnl-2021-325168 on 27 July 2021. D
ow
nloaded from
 
